CAS: 23504-03-2; 4-Isopropylbenzene-1,3-Diol

该化合物是一种多用途化合物,其特点是其独特的结构和氢氧基组,它为各种有机溶剂提供了高纯度和极佳的溶解性,该化合物因其在合成药物和农用化学品方面的潜在应用而具有价值,可以作为关键的中间体,其水利和脂利特性使它适合复杂的化学转化,为进一步衍生提供了一个稳定的平台.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

2,4-dimethoxy-1-(prop-1-en-2-yl)benzene isopropyl alcohol recorcinol 2',4'-dimethoxyacetophenone 1-(2,4-Dihydroxy-5-isopropyl-phenyl)-2,2,2-trifluoro-ethanone 4-bromo-6-isopropyl-benzene-1,3-diol 1-{3-[2,6-Dihydroxy-3-isopropyl-5-(2,2,2-trifluoro-acetyl)-benzyl]-2,4-dihydroxy-5-isopropyl-phenyl}-2,2,2-trifluoro-ethanone 1-(2,4-dihydroxy-5-isopropylphenyl)ethan-1-one

合成工艺路线路线简述

    2-(2,4-Dimethoxyphenyl)Propan-2-Ol置于三乙基硅烷,三溴化硼体系中,用 二氯甲烷,三氟乙酸 用作溶剂,化学反应 3.0H,反应生成4-异丙基苯-1,3-二醇
    参考文献:在环境条件下由有机碱介导的kolbe-schmitt型反应†
    标题:在环境条件下由有机碱介导的kolbe-schmitt型反应†
    摘要:间苯二酚有机碱的组合使用在环境条件下实现了kolbe-Schmitt型反应.当将间苯二酚(3-羟基苯酚衍生物)在二氧化碳气氛下用dbu处理时,亲核加成反应继续进行,从而以高收率得到了相应的水杨酸衍生物.
    Doi:10.1039/c9Cc04550C

    海关参考信息

    专利信息


    专利号:US-2008125587-A1
    优先权日:2006-05-25
    标 题 :Synthesis of triazole compounds that modulate HSP90 activity
    发明人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA
    权利人:CHIMMANAMADA DINESH U; LEE CHI-WAN; JAMES DAVID; ZHANG SHIJIE; YING WEIWEN; CHAE JUNGHYUN; PRZEWLOKA TERESA
    摘要:The present invention provides novel methods of preparing triazole compounds which inhibit the activity of Hsp90. One embodiment of the invention is directed to methods for preparing a triazole compound represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising the steps of: a) reacting an amide represented by the following Structural Formula: n n n n n n n n n n with a thionation reagent to form a thioamide; b) reacting the thioamide of step a) with hydrazine to form a hydrazonamide; c) reacting the hydrazonamide of step b) with a carbonylation or a thiocarbonylation reagent. n In one embodiment, the present invention is a method of synthesis of a compound of formula (IA) n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof, comprising reacting a compound of formula (IIA) n n n n n n n n n n with an oxidizing agent, thereby producing a compound of formula (IA). n The present invention is also directed to a method of preparing a compound or a tautomer thereof represented by the following Structural Formula: n n n n n n n n n n or a tautomer, a pharmaceutically acceptable salt, solvate, or clathrate, or a prodrug thereof. The method comprises the step of reacting a first starting compound represented by the following Structural Formula: n n n n n n n n n n in the presence of a mercuric salt, with a second starting compound represented by the following Structural Formula:

    专利号:WO-2025181827-A2
    优先权日:2024-02-26
    标 题:Process development for substituted resorcinol production from cyclohexane-1,3-diones
    发明人:DAS PRALAY; YAMINI; MEHRA PUSHKAR; KUMAR ASHISH; BAINS ROHIT; KUMAR AJAY; RAM SHANKAR; SHARMA DHARMINDER; CHAUHAN ARVIND SINGH
    权利人:COUNCIL SCIENT IND RES
    摘要:The invention provides a scalable and low cost process for synthesis of different high value 4-alkyl resorcinols such as 3-(2,4-dihydroxyphenyl)propanoic acid, 3-(2,4- dihydroxy-5-methylphenyl)-2-methylpropanoic acid, 4-methyl resorcinol, 4-isopropyl resorcinol and 4-hexyl resorcinol from their corresponding cyclohexane-1,3-diones. The present invention also provides a process for preparing cyclohexane-1,3-diones which is the starting materials for the synthesis of resorcinols.

    专利号:WO-2009075890-A2
    优先权日:2007-12-12
    标题 :Method for synthesis of triazole compounds that modulate hsp90 activity

    专利号:WO-2016009359-A1
    优先权日:2014-07-15
    标 题:Synthesis of 2,2-bis(3-phenyl-4-hydroxyphenyl) propane (php)

    专利号:US-10793848-B2
    优先权日:2014-01-31
    标题 :Immobilized proteins and use thereof
    发明人:CASSIMJEE KARIM ENGELMARK; BÄCKVALL JAN-ERLING
    权利人:ENGINZYME AB
    摘要:The invention relates to an immobilized protein material comprising a protein that is immobilized on a glass material or organic polymer through affinity tag binding. The glass material may be a porous glass material such as (hybrid) controlled porosity glass. The invention also relates to the use of an immobilized enzyme material as a heterogeneous biocatalyst in chemical synthesis. The invention further relates to a method for the immobilization of affinity tagged proteins on a glass material or organic polymer, and to a method for the purification and isolation of affinity tagged proteins by the immobilization of such proteins on a glass material or organic polymer.

    专利号:CN-107556164-B
    优先权日:2017-09-15
    标 题:Synthesis method of 4-isopropylresorcinol
    南通凯美瑞化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemistar.com.cn
    电话: 025-52643182 13914798241👤
    📞南通凯美瑞化工有限公司 ⚠️参考联系方式

    销售电话:025-52643182 13914798241
    邮箱:doria@chemipioneer.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    南京江恒医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.serpharm.cn
    电话: 13951936332 18305166317👤
    📞南京江恒医药化工有限公司 ⚠️参考联系方式

    销售电话:13951936332 18305166317
    邮箱:info@serpharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知